Peer-influenced content. Sources you trust. No registration required. This is HCN.
Northwestern Medicine
Prior research has revealed a potential link between damage to specific parts of the brain and repetitive addictive behaviors. In this report, with findings published in Nature Medicine, the investigators found that lesions that disrupted smoking and alcohol addiction behaviors occurred in many different brain locations and were characterized by a specific pattern of brain connectivity.
Neurology October 25th 2022
ACP Internist
The problem with many of the findings of cirrhosis is you have to specifically look for them or you will miss them. Here’s a tip for helping you not miss them.
Emergency Medicine October 20th 2022
JAMA Network
Gabapentin has been increasingly used as part of a multimodal analgesia regimen to reduce opioid use in perioperative pain management. In this cohort study of 237,872 adults aged 65 years or older, perioperative gabapentin users had significantly increased risk of delirium, new antipsychotic use, and pneumonia compared with nonusers after major surgery.
Anesthesiology October 3rd 2022
Medical Professionals Reference (MPR)
The colorful fentanyl, known as “rainbow fentanyl,” has been identified in 18 different states and has been found in a variety of forms, including pills, powder, and blocks that resemble sidewalk chalk, according to a press release from the agency. No particular color has been found to have a higher potency through testing. According to the DEA, every shade, shape, and size should be viewed as being exceedingly harmful.
Family Medicine/General Practice September 19th 2022
The recent United States Supreme Court ruling raises the bar for evidence that must be shown by the government in order to successfully prosecute doctors who prescribe excessive dosages of painkillers — a huge win for prescribers.
Anesthesiology September 12th 2022
Pharmacy Practice News
Sufentanil sublingual tablet 30 mcg (Dsuvia, AcelRx), an effective novel tablet formulation of the synthetic opioid sufentanil, has been given FDA approval for the management of severe acute pain in adult patients in licensed medically supervised healthcare settings. The medication is administered sublingually in a single-dose, prefilled applicator.
Clinical Pharmacology September 8th 2022